T1-Weighted Contrast Enhancement, Apparent Diffusion Coefficient, and Cerebral-Blood-Volume Changes after

Davide Negroni1, Romina Bono1, Eleonora Soligo2

  • 1Radiology Department, Maggiore della Carità Hospital of Novara, 28100 Novara, Italy.

Tomography (Ann Arbor, Mich.)
|February 24, 2023
PubMed
Abstract

Insights

Post-operative MRIs for glioblastoma surgery within 48 hours show distinct differences in tumor characteristics. Early imaging may improve detection of residual glioblastoma using perfusion techniques and calculating the relative Cerebral Blood Volume ratio.

Area of Science:

  • Neuro-oncology
  • Radiology
  • Medical Imaging

Background:

  • Glioblastoma multiforme (GBM) surgery requires accurate assessment of residual tumor.
  • Post-operative MRI timing is crucial for evaluating treatment effectiveness.
  • Standard imaging protocols may not fully capture early post-surgical changes.

Purpose of the Study:

  • To compare the diagnostic utility of post-operative MRIs performed within 48 hours versus after 48 hours in glioblastoma patients.
  • To identify advantages of early post-operative MRI in glioblastoma assessment.
  • To evaluate specific MRI parameters for residual tumor detection.

Main Methods:

  • 145 glioblastoma patients underwent post-operative MRI.
  • T1-weighted Contrast Enhancement (CE), Apparent Diffusion Coefficient (ADC), and Cerebral Blood Volume (rCBV) were analyzed.
  • Patients were grouped into early (≤48 h) and late (>48 h) post-operative MRI groups.

Main Results:

  • Significant differences in ADC and rCBV ratio values were observed between the early and late imaging groups (p < 0.05).
  • Early post-operative MRI (≤48 h) demonstrated potential advantages in detecting glioblastoma.
  • Artifacts impacted rCBV calculation in a subset of patients, highlighting the importance of imaging quality.

Conclusions:

  • MRI findings, including CE, rCBV, and ADC values, differ based on post-operative timing.
  • Performing MRI within 48 hours post-surgery may enhance glioblastoma detection using perfusion imaging.
  • The rCBV ratio calculation shows promise for early residual tumor assessment in glioblastoma.